StonvexLoading…
StonvexCore line items from BATL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $39.06M | $164.96M | $133.35M | $89.96M |
Operating Income | $-2.13M | $-6.64M | $4.06M | $3.24M |
Net Income | $-56.48M | $1.79M | $-735.00K | $4.80M |
EPS (Diluted) | $-3.72 | $-2.24 | $-1.48 | $-0.56 |
Total Assets | $412.37M | $460.68M | $491.69M | $498.78M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $46.37M | $27.96M | $50.45M | $44.62M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 20.54M | 16.46M | 16.46M | 16.46M |